Effects of Losartan on Fibrinolytic Parameters and von Willebrand Factor in Chinese Subjects with Hypertension: a Comparative Study versus Atenolol

Author： Liu J   Sun N-L   Yang J   Huang J-H  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.37, Iss.3, 2009-05, pp. : 595-600

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness of Losartan Versus Atenolol in Treating Hypertension—An Analysis of the LIFE Study from a Swiss Perspective

By Szucs Thomas   Burnier Michel   Erne Paul  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 5, 2004-09 ,pp. : 391-397

Springer Publishing Company

Access to resources Recommend Favorite

Losartan beats atenolol in hypertension with LVH

By  

Inpharma, Vol. 1, Iss. 1531, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Autonomic Effects of Nebivolol versus Atenolol in Healthy Subjects

By Chiladakis John   Georgiopoulou Ekaterini   Alexopoulos Dimitrios  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 6, 2004-11 ,pp. : 469-473

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Losartan and Delapril on the Fibrinolytic System in Patients with Mild to Moderate Hypertension

By Paterna S.  

Clinical Drug Investigation, Vol. 23, Iss. 11, 2003-01 ,pp. : 717-724

Adis International

Access to resources Recommend Favorite

A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy

By Anis Aslam H.   Sun Huiying  

PharmacoEconomics, Vol. 24, Iss. 4, 2006-01 ,pp. : 387-400

Adis International

Access to resources Recommend Favorite